Calendar
Ongoing COVID-19 trial: The ProPac-COVID trial
We are currently running an ongoing trial with the hypothesis that in patients who are urgently admitted and who have a positive test for 2019-nCoV and symptoms similar to COVID-19 disease, treatment with corona virus inhibitor hydroxychloroquine as well as virus-immunomodulatory and antibacterial drug azithromycin can lead to shorter hospitalisation and fewer admissions in the intensive care unit
Latest news
Contact information
Mia Moberg Co-founder of COP:TRIN, MD, PhD
Jens-Ulrik Jensen Coordinator and Contact person for the Steering Committee, MD, PhD
